Specialized Diagnostics DCL Medical Laboratories offers regional laboratory services with a focus on molecular diagnostics and women's health, presenting opportunities to cross-sell advanced testing panels, referral partnerships, and outsourced diagnostic solutions to clinics and hospitals seeking comprehensive pathology support.

Clinical Trials Partnering DCL provides anatomic pathology services in global clinical trials for pharmaceutical and medical device companies in collaboration with major central laboratories and CROs, suggesting sales potential in expanding contract research organization networks, trial site services, and matrixed testing support.

Midwest Expansion With operations across the Midwest and a lean revenue profile, there is room to target regional health systems, multi-site networks, and independent labs for regional distribution agreements, reference testing, and capacity-sharing arrangements to scale volumes.

Private Equity Backing Principal equity by Thompson Street Capital Partners indicates potential for growth initiatives, strategic acquisitions, and capital investments to expand service lines, lab capacity, and technology adoption that can be co-sold to enterprise accounts.

Private-Labeled Services DCL’s consultative pathology services and private company positioning create opportunities to offer white-labeled diagnostic solutions, managed service contracts, and scalable testing for health networks seeking to enhance quality, speed, and patient outcomes.